Inflammatory diseases of the external ear: place and possibilities of topical therapy

Otitis externa (NO) is manifested by inflammatory changes in the auricle, external auditory canal and epidermal layer of eardrum. The disease characterized a wide prevalence continuing increase morbidity, persistent, resistant to adequate therapy course frequent recurrence pathological process. For development NO, presence an etiotropic agent violation integrity skin endogenous exogenous nature are necessary. According area distribution type process, limited diffuse NO considered. Most often, bacteria act as causative agents with forms Pseudomonas aeruginosa leader. appointment systemic antibiotics for uncomplicated impractical, it optimal use topical combined drugs that have activity against main pathogens NO. advantages such patients rapid accumulation required active substance concentration inflammation almost complete lack action, minimal risk spread strains microorganisms. It antimicrobial been shown be otitis externa. reduction pain also important component management OE. A good option ear drug local anesthetic action containing antibacterial components: aminoglycoside neomycin sulfate cyclic polypeptide polymyxin B sulfate, lidocaine hydrochloride. Such balanced high safety can recommended